Skip to main content
. 2020 Oct 20;107(8):657–666. doi: 10.1136/heartjnl-2020-317101

Table 5.

Mortality and in-hospital medical complications after AMI, stratified by diabetes status

Clinical outcomes Without diabetes (n=2008, 57.4% of 3501 participants)
(a)
Newly diagnosed diabetes (n=508, 14.5% of 3501 participants)
(b)
Established diabetes (n=985, 28.1% of 3501 participants)
(c)
P value*
(b) vs (a)
P value†
(b) vs (c)
Mortality
 In-hospital mortality 1 (0.1%) 0 3 (0.3%) 0.555 0.999
 30-day mortality 12 (0.6%) 0 9 (0.9%) 0.026 0.011
 1-year mortality 32 (1.6%) 5 (0.9%) 35 (3.6%) 0.0009 0.015
In-hospital medical complications
 Re-infarction 28 (1.4%) 6 (1.2%) 9 (0.9%) 0.403 0.927
 Heart failure 109 (5.4%) 36 (7.1%) 97 (9.9%) 0.176 0.214
 Cardiac arrhythmias 151 (7.5%) 32 (6.3%) 65 (6.6%) 0.522 0.607
 Stroke/Transient ischaemic attack 6 (0.3%) 2 (0.4%) 4 (0.4%) 0.892 0.912
 Haemorrhagic complications 153 (7.6%) 38 (7.5%) 80 (8.1%) 0.489 0.921

P value numbers in bold denote statistical significance at the p<0.05 level.

*Unadjusted p values were testing for clinical outcomes differences between patients with newly diagnosed and no diabetes. Fisher’s exact for cells<5.

†Unadjusted p values were testing for clinical outcomes differences between patients with newly diagnosed and established diabetes. Fisher’s exact test for cells<5.

AMI, acute myocardial infarction.